Limited joint mobility (LJM) in elderly subjects with type II diabetes mellitus (Q44014163)

28 November 2017

title

Limited joint mobility (LJM) in elderly subjects with type II diabetes mellitus (English)

1 reference

28 November 2017

0 references

Michele Abate

1 reference

28 November 2017

Cosima Schiavone

series ordinal

1 reference

28 November 2017

Patrizia Pelotti

series ordinal

1 reference

28 November 2017

Vincenzo Salini

series ordinal

1 reference

28 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20940076

31 July 2024

publication date

10 October 2010

1 reference

full work available at URL

28 November 2017

https://api.elsevier.com/content/article/PII:S0167494310002347?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

https://api.elsevier.com/content/article/PII:S0167494310002347?httpAccept=text/plain

31 July 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Archives of Gerontology and Geriatrics

31 July 2024

published in

1 reference

28 November 2017

1 reference

28 November 2017

1 reference

28 November 2017

page(s)

135-140

1 reference

Diagnosis and Classification of Diabetes Mellitus

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Limited joint mobility in non-insulin-dependent diabetic (NIDDM) patients: correlation to control of diabetes, atherosclerotic vascular disease, and other diabetic complications

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Shoulder adhesive capsulitis and shoulder range of motion in type II diabetes mellitus: association with diabetic complications

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Morphological changes of skeletal muscle, tendon and periosteum in the senescence-accelerated mouse (SAMP6): a murine model for senile osteoporosis

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Rheumatologic manifestations of diabetes mellitus

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Contribution of Plantar Fascia to the Increased Forefoot Pressures in Diabetic Patients

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

The AGE of the matrix: chemistry, consequence and cure

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Non-enzymatic interactions of glyoxylate with lysine, arginine, and glucosamine: a study of advanced non-enzymatic glycation like compounds

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

31 July 2024

Ultrasound of the knee

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Limited joint mobility in type 1 diabetic patients: associations with microangiopathy and subclinical macroangiopathy are different in men and women

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Walking Strategy in Diabetic Patients With Peripheral Neuropathy

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Advanced glycation end products: sparking the development of diabetic vascular injury

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Loss of muscle strength during aging studied at the gene level

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Joint contracture—common manifestation of childhood diabetes mellitus

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Differences in ankle joint complex range of motion as a function of age.

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Diabetic retinopathy and its association with limited joint mobility

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Does stretching induce lasting increases in joint ROM? A systematic review

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Hand abnormalities are associated with the complications of diabetes in type 2 diabetes

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Activation of the Receptor for Advanced Glycation End Products Triggers a p21 -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Reduced prevalence of limited joint mobility in type 1 diabetes in a U.K. clinic population over a 20-year period

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Limited joint mobility of the hand: prevalence and relation to chronic complications in non-insulin-dependent diabetes mellitus patients

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Differences in range of motion between dominant and nondominant sides of upper and lower extremities

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Effects of age on passive range of motion of selected peripheral joints in healthy adult females.

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Non-enzymatic glycosylation of a type I collagen matrix: effects on osteoblastic development and oxidative stress

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Microalbuminuria is associated with limited joint mobility in type I diabetes mellitus

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Rotator cuff tears: clinical, radiographic, and US findings

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

31 July 2024

Ultrasound of the ankle

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Plasticity of the muscle-tendon complex with disuse and aging

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Ageing of human muscles and tendons

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Range of motion of the foot as a function of age

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Therapeutic and physical fitness exercise prescription for older adults with joint disease: an evidence-based approach

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Reconstructed skin modified by glycation of the dermal equivalent as a model for skin aging and its potential use to evaluate anti-glycation molecules

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Limitation of joint mobility and shoulder capsulitis in insulin- and non-insulin-dependent diabetes mellitus

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

The diabetic hand: a forgotten complication?

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

The influence of diabetes mellitus on joint mobility

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Does stretching increase ankle dorsiflexion range of motion? A systematic review

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Novel inhibitors of glycation and AGE formation

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Upper limb musculoskeletal abnormalities and poor metabolic control in diabetes

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Ankle ROM and stiffness measured at rest and during gait in individuals with and without diabetic sensory neuropathy

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Myotendinous plasticity to ageing and resistance exercise in humans.

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Normal hip and knee active range of motion: the relationship to age.

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Skeletal and Joint Manifestations of Childhood Diabetes

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Limitation of finger joint mobility in diabetes mellitus

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Limited joint mobility in insulin dependent childhood diabetes

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Connective tissue and joint disease in diabetes mellitus

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

From the RSNA refresher courses: US of the rotator cuff: pitfalls, limitations, and artifacts

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Relationships between plantar flexor muscle stiffness, strength, and range of motion in subjects with diabetes-peripheral neuropathy compared to age-matched controls.

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Limited joint mobility in selected hand and foot joints in patients with type 1 diabetes mellitus: a methodology comparison

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

A quantitative assessment of limited joint mobility in patients with diabetes. Goniometric analysis of upper extremity passive range of motion

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Proprioceptive neuromuscular facilitation stretching : mechanisms and clinical implications

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Limited joint mobility in adults with diabetes mellitus

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Musculoskeletal manifestations of diabetes mellitus

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Limited joint mobility (LJM) of the hand in patients with diabetes mellitus: relation to chronic complications

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

RAGE activation induces invasiveness of RA fibroblast-like synoviocytes in vitro

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Rapid hydrolysis and slow α,β-dicarbonyl cleavage of an agent proposed to cleave glucose-derived protein cross-links

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Soluble forms of RAGE in internal medicine.

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Enzymatic deglycation of proteins

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

AGE-breakers cleave model compounds, but do not break Maillard crosslinks in skin and tail collagen from diabetic rats

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

31 July 2024

Exercise for arthritis

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

The use of glucosamine therapy in osteoarthritis

31 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCHGER.2010.09.011

31 July 2024

Identifiers

DOI

1 reference

28 November 2017

1 reference